about
sameAs
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT.Methodological considerations in quantification of oncological FDG PET studies.The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patientsGadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.FDG-PET/CT based response-adapted treatment.Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery.The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.False positive 18F-FDG PET/CT due to inflamed concha bullosa.Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.PET in the management of locally advanced and metastatic NSCLC.Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer.Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.The value of (18)F-FDG-PET/CT in diagnosis and during follow-up in 273 patients with chronic Q fever.Metal artifact reduction of CT scans to improve PET/CT.18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality.New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic 18F Fluorodeoxyglucose PET.A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis.The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer.Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tDiagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression.Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT.The impact of respiratory gated positron emission tomography on clinical staging and management of patients with lung cancer.Improving the Spatial Alignment in PET/CT Using Amplitude-Based Respiration-Gated PET and Respiration-Triggered CT.Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy.Nodular fasciitis on F-18 FDG PET.A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment.Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients.The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer.18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy.Shortened dynamic (18)F-FDG PET.
P50
Q33413585-6AD69964-55A5-446A-9E7F-205324667465Q33915164-DAB34A5E-9C77-4CEB-ADCD-9DA82787F309Q34166842-484C5A7D-ACB1-4B0D-9F61-9361F856D5DBQ36181301-ADB5779C-FF11-44AB-AC49-BF38829710AEQ36267810-77817E04-2950-4A51-9906-844C9DF9770CQ36286595-6609C78F-476E-485D-8B7C-2739FB132715Q37116520-62431FE3-1ABD-449A-9B21-E51DEE1D059FQ37464549-3938D4E8-4354-43EB-8248-E97BB80D80B1Q37690773-1C897794-5CBF-4231-B96F-341D0177B7E1Q37857025-CDFAD7AF-E9B9-418B-9B6B-1D0077D374E6Q37999965-3328DA05-7289-45DD-9825-FE2EF0994655Q38434409-755A7065-6C94-463F-AF08-0B842B37B828Q38444980-F473ED63-E2E9-47D1-ACB2-BAEB1C92FF3BQ38482807-40B0C18F-335B-4C03-BC3F-2B62207273EDQ38669499-E98B6419-CA43-4B53-B093-F09693BA40D6Q38762851-0C3A933F-DF6A-47E5-A177-C4C3B7C303BBQ38793808-F44D9D15-BE18-4562-973A-D1AE745EFF09Q38880970-3D7B094F-6928-4D27-BA4F-6F52DE3AFC70Q39005990-607A44FF-EB76-4629-84D6-6D0A5D98B817Q39009389-1F310F3D-095D-465E-A6DE-9E2691EECD92Q39674145-A49D479B-3C82-4CC2-B880-009D4C22DF5EQ39694594-6D0B91F7-86E2-4E71-9761-F3AFA85572E8Q39929954-8879815A-2486-4CA9-B173-37D47655A5FFQ40064495-41DFA9B4-7610-40CB-9CA5-20578439ECD5Q40205723-C3B4F51E-EEBB-4DF4-897A-25AA71131D5EQ40443337-0A85C268-90F2-45C9-91C6-22E004EB89E8Q40489959-900CC6B6-A8F8-4919-80A4-D4FFBFF82715Q40526283-25C49B73-FF12-4562-95DF-93219B720E59Q40755016-B887058C-8426-4500-9518-5BFDF672E882Q42908621-10F5E378-9145-4698-AD6F-18EC659B15B8Q43243188-2EAA4B74-9030-4123-9785-4463DEBF69B4Q43456163-9AAD23A3-893C-4A30-A81E-F59B23AF1CB9Q43560029-A91FFCEF-30D7-4ED5-90C9-99CD0CDA7993Q43617653-98152887-25A8-4A6A-A252-DE98433B54CFQ43819957-FE33E811-78B3-4079-989D-6F0DFC141F43Q43953671-12F7C588-E0F3-4DA3-AAF3-8C7DA60EE5C1Q44659473-B22E735B-0DE0-4FD3-9BA5-B4DD05B02EB7Q45954854-19342848-9489-4BEB-8138-66864D849482Q46570655-CC02993B-5AC5-4DF3-8EF7-01890EFAEA83Q46877419-858FF542-4A34-40C1-9330-EAE6B4FA3A10
P50
description
hoogleraar aan de Universiteit Leiden
@nl
profesore universitare
@sq
university teacher
@en
հետազոտող
@hy
name
Lioe-Fee de Geus-Oei
@ast
Lioe-Fee de Geus-Oei
@en
Lioe-Fee de Geus-Oei
@es
Lioe-Fee de Geus-Oei
@nl
Lioe-Fee de Geus-Oei
@sl
type
label
Lioe-Fee de Geus-Oei
@ast
Lioe-Fee de Geus-Oei
@en
Lioe-Fee de Geus-Oei
@es
Lioe-Fee de Geus-Oei
@nl
Lioe-Fee de Geus-Oei
@sl
altLabel
Lioe-F. de Geus-Oei
@nl
prefLabel
Lioe-Fee de Geus-Oei
@ast
Lioe-Fee de Geus-Oei
@en
Lioe-Fee de Geus-Oei
@es
Lioe-Fee de Geus-Oei
@nl
Lioe-Fee de Geus-Oei
@sl
P1006
P214
P1006
P1053
B-2716-2014
J-5901-2015
P19
P21
P214
P31
P3829
P496
0000-0003-1817-2743
P569
1971-01-01T00:00:00Z
P7449
PRS1331370
P7859
viaf-291277639